Clinical Trials for Atsena Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Atsena Therapeutics

Clinical Trials (2)

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

PHASE1/PHASE2Recruiting

21 participants

Started: Aug 22, 2023 · Completed: Oct 31, 2029

1 condition1 sponsor4 locations

Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D

PHASE1/PHASE2Active, not recruiting

15 participants

Started: Sep 12, 2019 · Completed: May 19, 2027

3 conditions1 sponsor2 locations